Article Details

In-Depth: Why developing antivirals is such a challenge for COVID

Retrieved on: 2021-03-18 23:48:45

Tags for this article:

Click the tags to see associated articles and topics

In-Depth: Why developing antivirals is such a challenge for COVID. View article details on hiswai:

Excerpt

That treatment is remdesivir. Outside of a few blends of monoclonal antibodies that have emergency authorizations, remdesivir is our only ...

Article found on: www.10news.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up